- SEK11.25bn
- SEK11.07bn
- SEK2.06bn
Annual balance sheet for Biotage AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 371 | 311 | 441 | 594 | 434 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 207 | 207 | 265 | 386 | 404 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 752 | 774 | 1,031 | 1,447 | 1,323 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 104 | 128 | 162 | 284 | 330 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 1,434 | 1,992 | 2,339 | 4,931 | 5,104 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 217 | 313 | 417 | 705 | 573 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 444 | 621 | 702 | 1,274 | 991 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 990 | 1,371 | 1,637 | 3,657 | 4,113 |
Total Liabilities & Shareholders' Equity | 1,434 | 1,992 | 2,339 | 4,931 | 5,104 |
Total Common Shares Outstanding |